Results 151 to 160 of about 1,220,527 (364)

Bosonic algebraic approach applied to the $\left[QQ\right]\left[\overline{Q}\overline{Q}\right]$ tetraquarks

Physical Review, 2022
The exact eigenenergies of the T4c=[cc][c¯c¯], T4b=[bb][b¯b¯], and T2[bc]=[bc][b¯c¯] tetraquarks are calculated within the extended transitional Hamiltonian approach, in which the so-called Bethe ansatz within an infinite-dimensional Lie algebra is used.
Majarshin, A. J., Luo, Yan-An, Pan, Feng, Segovia, J.   +3 more
openaire  

Function‐driven design of a surrogate interleukin‐2 receptor ligand

FEBS Letters, EarlyView.
Interleukin (IL)‐2 signaling can be achieved and precisely fine‐tuned through the affinity, distance, and orientation of the heterodimeric receptors with their ligands. We designed a biased IL‐2 surrogate ligand that selectively promotes effector T and natural killer cell activation and differentiation. Interleukin (IL) receptors play a pivotal role in
Ziwei Tang, Zelin Cheng, Teng Li, Fulian Wang, Liangminghui Zhang, Xiuxiu He, Lili Liu, Wei Wang, Aibin Liang, Guang Yang   +9 more
wiley   +1 more source

Revisiting semileptonic $B^{-}\to p\overline{p}{\ell }^{-}{\overline{\nu }}_{\ell }$ decays

Physical Review, 2021
We systematically revisit the baryonic four-body semileptonic decays of B−→BB¯′ℓ−ν¯ℓ by the perturbative QCD counting rules with B representing octet baryons and ℓ=e, μ. We study the transition form factors of B−→BB¯′ in the limit of (pB+pB¯′)2→∞ with the three-body B¯→BB¯′M and B−→pp¯μ−ν¯μ data along with SU(3)f flavor symmetry. We calculate the decay
Geng, C. Q., Liu, Chia-Wei, Tsai, Tien-Hsueh   +2 more
openaire  

β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1

Molecular Oncology, EarlyView.
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero, Alejandro Belmonte‐Fernández, Mónica González‐Moreno, Laura Rodríguez‐Cordero, Begoña Pérez‐Valderrama, Joaquín Herrero‐Ruíz, Francisco Romero, Carmen Sáez, Miguel Á. Japón   +8 more
wiley   +1 more source

Reduced dopant-induced scattering in remote charge-transfer-doped MoS ₂ field-effect transistors [PDF]

, 2022
Juntae Jang, Jae‐Keun Kim, Jiwon Shin, Jaeyoung Kim, Kyeong‐Yoon Baek, Jaehyoung Park, Seung Min Park, Young Duck Kim, S. Parkin, Keehoon Kang, Kyungjune Cho, Takhee Lee   +11 more
openalex   +1 more source

Nicotinamide N‐methyltransferase promotes drug resistance in lung cancer, as revealed by nascent proteomic profiling

Molecular Oncology, EarlyView.
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou, Zhen Wang, Fei Yang, Xiao Han, Lei Li, Huadong Liu   +5 more
wiley   +1 more source

DETERMINANT FACTORS OF THE INVESTMENT PERFORMANCE OF VOLUNTARY PENSION FUNDS IN ROMANIA [PDF]

The goal of this paper is to give an overview of the voluntary private pension system.In the beginning it presents both the features and the legal framework that guide the functioning ofthese pension funds in our country and the basic descriptive data ...
Luiza Mos, Victoria Seulean
core  

Crystal water intercalated interlayer expanded MoS₂ nanosheets as a cathode for efficient zinc-ion storage

, 2023
Muruganandham Hariram, Manoj Kumar, Kamlendra Awasthi, Debasish Sarkar, Prashanth W. Menezes   +4 more
openalex   +2 more sources

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source